194 related articles for article (PubMed ID: 35130611)
1. Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC.
Yang H; Zhao H; Ren Z; Yi X; Zhang Q; Yang Z; Kuang Y; Zhu Y
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):220-231. PubMed ID: 35130611
[TBL] [Abstract][Full Text] [Related]
2. WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC.
Wang R; Zhao J; Jin J; Tian Y; Lan L; Wang X; Zhu L; Wang J
Lipids Health Dis; 2022 Nov; 21(1):121. PubMed ID: 36384580
[TBL] [Abstract][Full Text] [Related]
3. HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism.
Du W; Zhang L; Brett-Morris A; Aguila B; Kerner J; Hoppel CL; Puchowicz M; Serra D; Herrero L; Rini BI; Campbell S; Welford SM
Nat Commun; 2017 Nov; 8(1):1769. PubMed ID: 29176561
[TBL] [Abstract][Full Text] [Related]
4. ACACA reduces lipid accumulation through dual regulation of lipid metabolism and mitochondrial function via AMPK- PPARα- CPT1A axis.
Dong J; Li M; Peng R; Zhang Y; Qiao Z; Sun N
J Transl Med; 2024 Feb; 22(1):196. PubMed ID: 38395901
[TBL] [Abstract][Full Text] [Related]
5. Effects of hypoxic exercise training on microRNA expression and lipid metabolism in obese rat livers.
Lu YL; Jing W; Feng LS; Zhang L; Xu JF; You TJ; Zhao J
J Zhejiang Univ Sci B; 2014 Sep; 15(9):820-9. PubMed ID: 25183036
[TBL] [Abstract][Full Text] [Related]
6. HIF-2α-induced upregulation of CD36 promotes the development of ccRCC.
Liao M; Li Y; Xiao A; Lu Q; Zeng H; Qin H; Zheng E; Luo X; Chen L; Ruan XZ; Yang P; Chen Y
Exp Cell Res; 2022 Dec; 421(2):113389. PubMed ID: 36252650
[TBL] [Abstract][Full Text] [Related]
7. Ror1 promotes PPARα-mediated fatty acid metabolism in astrocytes.
Tanaka Y; Minami Y; Endo M
Genes Cells; 2023 Apr; 28(4):307-318. PubMed ID: 36811220
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.
Cheng Y; Dharancy S; Malapel M; Desreumaux P
World J Gastroenterol; 2005 Dec; 11(48):7591-6. PubMed ID: 16437683
[TBL] [Abstract][Full Text] [Related]
9. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
[TBL] [Abstract][Full Text] [Related]
10. Lipid in Renal Carcinoma: Queen Bee to Target?
Tan SK; Welford SM
Trends Cancer; 2020 Jun; 6(6):448-450. PubMed ID: 32459999
[TBL] [Abstract][Full Text] [Related]
11. PPARα regulates tumor cell proliferation and senescence via a novel target gene carnitine palmitoyltransferase 1C.
Chen Y; Wang Y; Huang Y; Zeng H; Hu B; Guan L; Zhang H; Yu AM; Johnson CH; Gonzalez FJ; Huang M; Bi H
Carcinogenesis; 2017 Apr; 38(4):474-483. PubMed ID: 28334197
[TBL] [Abstract][Full Text] [Related]
12. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin stimulates lipid metabolism via AMPK in rabbit blastocysts.
Schindler M; Pendzialek M; Grybel KJ; Seeling T; Gürke J; Fischer B; Navarrete Santos A
Hum Reprod; 2017 Jul; 32(7):1382-1392. PubMed ID: 28472298
[TBL] [Abstract][Full Text] [Related]
14. CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS/PPARγ/NF-κB pathway in clear cell renal cell carcinoma.
Zeng K; Li Q; Song G; Chen B; Luo M; Miao J; Liu B
Cell Signal; 2023 Oct; 110():110838. PubMed ID: 37541641
[TBL] [Abstract][Full Text] [Related]
15. AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma.
Chen C; Zhao W; Lu X; Ma Y; Zhang P; Wang Z; Cui Z; Xia Q
Cancer Sci; 2022 Aug; 113(8):2600-2615. PubMed ID: 35633317
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma.
Riscal R; Bull CJ; Mesaros C; Finan JM; Carens M; Ho ES; Xu JP; Godfrey J; Brennan P; Johansson M; Purdue MP; Chanock SJ; Mariosa D; Timpson NJ; Vincent EE; Keith B; Blair IA; Skuli N; Simon MC
Cancer Discov; 2021 Dec; 11(12):3106-3125. PubMed ID: 34244212
[TBL] [Abstract][Full Text] [Related]
17. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Cannabinoid Receptor 1 Can Influence the Lipid Metabolism in Mice with Diet-Induced Obesity.
Wei LW; Yuan ZQ; Zhao MD; Gu CW; Han JH; Fu L
Biochemistry (Mosc); 2018 Oct; 83(10):1279-1287. PubMed ID: 30472964
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth.
Deberardinis RJ; Lum JJ; Thompson CB
J Biol Chem; 2006 Dec; 281(49):37372-80. PubMed ID: 17030509
[TBL] [Abstract][Full Text] [Related]
20. Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.
Li DY; Lin FF; Li GP; Zeng FC
Kaohsiung J Med Sci; 2021 Nov; 37(11):973-982. PubMed ID: 34337864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
